Seasonal Malaria Chemoprevention Drug Levels and Drug Resistance Markers in Children With or Without Malaria in Burkina Faso: A Case-Control Study
- 23 May 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 228 (7) , 926-935
Abstract
Background: Despite scale-up of seasonal malaria chemoprevention (SMC) with sulfadoxine-pyrimethamine and amodiaquine (SP-AQ) in children 3–59 months of age in Burkina Faso, malaria incidence remains high, raising concerns regarding SMC effectiveness and selection of drug resistance. Using a case-control design, we determined associations between SMC drug levels, drug resistance markers, and presentation with malaria. Methods: We enrolled 310 children presenting at health facilities in Bobo-Dioulasso. Cases were SMC-eligible children 6–59 months of age diagnosed with malaria. Two controls were enrolled per case: SMC-eligible children without malaria; and older (5–10 years old), SMC-ineligible children with malaria. We measured SP-AQ drug levels among SMC-eligible children and SP-AQ resistance markers among parasitemic children. Conditional logistic regression was used to compute odds ratios (ORs) comparing drug levels between cases and controls. Results: Compared to SMC-eligible controls, children with malaria were less likely to have any detectable SP or AQ (OR, 0.33 [95% confidence interval, .16–.67]; P = .002) and have lower drug levels (P < .05). Prevalences of mutations mediating high-level SP resistance were rare (0%–1%) and similar between cases and SMC-ineligible controls (P > .05). Conclusions: Incident malaria among SMC-eligible children was likely due to suboptimal levels of SP-AQ, resulting from missed cycles rather than increased antimalarial resistance to SP-AQ.Keywords
Funding Information
- National Institute of Allergy and Infectious Diseases
- National Institutes of Health (5R01 AI117001)
This publication has 28 references indexed in Scilit:
- Prevalence ofPlasmodium falciparumparasites resistant to sulfadoxine/pyrimethamine in pregnant women in Yaoundé, Cameroon: emergence of highly resistantpfdhfr/pfdhpsallelesJournal of Antimicrobial Chemotherapy, 2015
- The effect of dose on the antimalarial efficacy of artemether–lumefantrine: a systematic review and pooled analysis of individual patient dataThe Lancet Infectious Diseases, 2015
- Impact of Antimalarial Treatment and Chemoprevention on the Drug Sensitivity of Malaria Parasites Isolated from Ugandan ChildrenAntimicrobial Agents and Chemotherapy, 2015
- Potential of the test-negative design for measuring influenza vaccine effectiveness: a systematic reviewExpert Review of Vaccines, 2014
- A molecular marker of artemisinin-resistant Plasmodium falciparum malariaNature, 2013
- Mapping ‘partially resistant’, ‘fully resistant’, and ‘super resistant’ malariaTrends in Parasitology, 2013
- A systematic review and meta-analysis of evidence for correlation between molecular markers of parasite resistance and treatment outcome in falciparum malariaMalaria Journal, 2009
- Emergence of adhfrMutation Conferring High‐Level Drug Resistance inPlasmodium falciparumPopulations from Southwest UgandaThe Journal of Infectious Diseases, 2008
- WHO Child Growth Standards based on length/height, weight and ageActa Paediatrica, 2006
- Mechanisms of Resistance of Malaria Parasites to AntifolatesPharmacological Reviews, 2005